Poly(Lactide-co-Glycolide) Nanoparticles, Layer by Layer Engineered for the Sustainable Delivery of AntiTNF-α

Macromolecular Bioscience

Volumn 13, Issue 7, 2013, Pages 903-912

  Romero, Gabriela ^a   Ochoteco, Olaia ^a   Sanz, David J ^a   Estrela Lopis, Irina ^b   Donath, Edwin ^b   Moya, Sergio E ^a  

^a CIC BIOMAGUNE   (Spain)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

AntiTNF ; Layer by layer assembly; Nanoparticles; Poly(lactide co glycolide); Sustainable release

Indexed keywords

CONFOCAL RAMAN MICROSCOPY; FIRST ORDER KINETICS; LAYER-BY-LAYER ASSEMBLIES; POLY LACTIDE-CO-GLYCOLIDE; QUARTZ CRYSTAL MICROBALANCE WITH DISSIPATION; SUSTAINABLE DELIVERY; SUSTAINABLE RELEASE; ZETA POTENTIAL MEASUREMENTS;

ALGINATE; AMINO ACIDS; ANTIBODIES; CELL CULTURE; COPOLYMERS; POLYETHYLENES;

NANOPARTICLES;

ADALIMUMAB; ALGINIC ACID; LYSOZYME; NANOPARTICLE; POLYCATION; POLYGLACTIN; POLYLYSINE;

ARTICLE; CONFOCAL MICROSCOPY; DRUG DELIVERY SYSTEM; DRUG RELEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; IONIC STRENGTH; NANOENCAPSULATION; PROTEIN ASSEMBLY; PROTEIN STABILITY; QUARTZ CRYSTAL MICROBALANCE; ZETA POTENTIAL;

ANTITNF-Α; LAYER BY LAYER ASSEMBLY; NANOPARTICLES; POLY(LACTIDE-CO-GLYCOLIDE); SUSTAINABLE RELEASE;

ALGINATES; ANTIBODIES, ANTI-IDIOTYPIC; DRUG DELIVERY SYSTEMS; GLUCURONIC ACID; HEP G2 CELLS; HEXURONIC ACIDS; HUMANS; NANOPARTICLES; POLYGLACTIN 910; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84880703574     PISSN: 16165187     EISSN: 16165195     Source Type: Journal    
DOI: 10.1002/mabi.201200478     Document Type: Article

References (18)

1. a) F. C. Breedveld, Lancet 2000, 355, 735; b) O. H. Brekke, I. Sandlie, Nat. Rev. Drug Discovery 2003, 2, 5.
2. J. Kempeni, Ann. Rheum. Dis. 1999, 58, I7.
3. a) M. F. Zambaux, F. Bonneaux, R. Gref, P. Maincent, E. Dellacherie, M. J. Alonso, P. Labrude, C. Vigneron, J. Controlled Release 1998, 50, 31; b) E. Allémann, J. C. Leroux, R. Gurny, E. Doelker, Pharm. Res. 1993, 10, 1732.
4. a) H. Cohen, R. J. Levy, J. Gao, I. Fishbein, V. Kousaev, S. Sosnowski, S. Slomkowski, G. Golomb, Gene Ther. 2000, 7, 1896; b) X. Yuan, L. Li, A. Rathinavelu, J. Hao, M. Narasimhan, M. He, V. Heitlage, L. Tam, S. Vigar, M. Salehi, J. Nanosci. Nanotechnol. 2006, 9-10, 2821; c) Y. B. Patil, S. K. Swaminathan, T. Sadhukha, L. Ma, J. Panyam, Biomaterials 2010, 31, 358; d) T. A. M. Ishihara, Expert Opin. Drug Delivery 2010, 7, 565; e) R. Langer, Science 1990, 249, 1527; f) M. L. Hans, A. M. Lowman, Curr. Opin. Solid State Mater. Sci. 2002, 6, 319; g) K. E. Uhrich, S. M. Cannizzaro, R. S. Langer, K. M. Shakesheff, Chem. Rev. 1999, 99, 3181.
5. Y.-Y. Yang, H.-H. Chia, T.-S. Chung, J. Controlled Release 2000, 69, 81.
6. a) S. Hornig, T. Heinze, C. R. Becer, U. S. Schubert, J. Mater. Chem. 2009, 19, 3838; b) U. Bilati, E. Allémann, E. Doelker, Eur. J. Pharm. Sci. 2005, 24, 67.
7. D. M. K. Jensen, D. Cun, M. J. Maltesen, S. Frokjaer, H. M. Nielsen, C. Foged, J. Controlled Release 2010, 142, 138.
8. a) H. Fessi, F. Piusieux, J. P. Devissaguet, N. Ammoury, S. Benita, Int. J. Pharm. 1989, 55, R1; b) P. B. O'Donnell, J. W. McGinity, Adv. Drug Delivery Rev. 1997, 28, 25; c) M. F. Zambaux, F. Bonneaux, R. Gref, E. Dellacherie, C. Vigneron, J. Controlled Release 1999, 60, 179; d) A. L. Doiron, K. A. Homan, S. Emelianov, L. Brannon-Peppas, Pharm. Res. 2009, 26, 674.
9. a) G. Decher, J. D. Hong, J. Schmitt, Thin Solid Films, 1992, 210, 831; b) G. Decher, Science 1997, 277, 1232.
10. a) S. T. Dubas, J. B. Schlenoff, Macromolecules 1999, 32, 8153; b) J. B. Schlenoff, S. T. Dubas, Macromolecules 2001, 34, 592; c) X. Arys, A. Laschewsky, A. M. Jonas, Macromolecules, 2001, 34, 3318; d) B. Schoeler, G. Kumaraswamy, F. Caruso, Macromolecules 2002, 35, 889.
11. a) N. G. Balabushevitch, G. B. Sukhorukov, N. A. Moroz, D. V. Volodkin, N. I. Larionova, E. Donath, H. Mohwald, Biotechnol. Bioeng. 2001, 76, 207; b) G. Berth, A. Voigt, H. Dautzenberg, E. Donath, H. Möhwald, Biomacromolecules 2002, 3, 579.
12. a) X. Su, B.-S. Kim, S. R. Kim, P. T. Hammond, D. J. Irvine, ACS Nano 2009, 3, 3719; b) T. Mauser, C. Déjugnat, G. B. Sukhorukov, Macromol. Rapid Commun. 2004, 25, 1781.
13. U. Reibetanz, C. Claus, E. Typlt, J. Hofmann, E. Donath, Macromol. Biosci. 2006, 6, 153.
14. P. D. Scholes, A. G. A. Coombes, L. Illum, S. S. Davis, M. Vert, M. C. Davies, J. Controlled Release 1993, 25, 145.
15. D. A. Rodriguez, C. Moncada, M. T. Núñez, S. Lavandero, B. C. Ponnappa, Y. Israel, Alcohol 2004, 33, 9.
16. I. Estrella Lopis, G. Romero, J. Zhou, E. Rojas, A. Franco, C. Sanchez Espinal, A. González Fernández, C. Gao, E. Donath, S. Moya, Biomacromolecules 2010, 11, 2993.
17. D. Tracey, L. Klareskog, E. H. Sasso, J. G. Salfeld, P. P. Tak, Pharmacol. Ther. 2008, 117, 244.
18. a) G. Romero, I. Estrela-Lopis, P. Castro-Hartmann, E. Rojas, I. Llarena, D. Sanz, E. Donath, S. E. Moya, Soft Matter 2011, 7, 6883; b) G. Romero, E. Rojas, I. Estrela-Lopis, E. Donath, S. Moya, Nanoscale Res. Lett. 2011, 6.